Author:
Lyseng-Williamson Katherine A.,Keating Gillian M.
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: updated 2014. Bethesda: Global Initiative for Chronic Obstructive Lung Disease; 2014.
2. Human medicines: European public assessment reports. London: European Medicines Agency; 2014.
3. Barnes PJ. The pharmacological properties of tiotropium. Chest. 2000;117(2 Suppl):63S–6S.
4. Tautermann CS, Kiechle T, Seeliger D, et al. Molecular basis for the long duration of action and kinetic selectivity of tiotropium for the muscarinic M3 receptor. J Med Chem. 2013;56(21):8746–56.
5. Spiriva (tiotropium) Respimat 2.5 micrograms, inhalation solution: EU summary of product characteristics. Ingelheim am Rhein: Boehringer Ingelheim International GmbH; 2014.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献